How can we optimize treatment of HER2-positive metastatic breast cancer?
Publication
, Journal Article
Hamilton, EP; Blackwell, KL
Published in: Oncology (Williston Park, N.Y.)
March 1, 2013
Duke Scholars
Published In
Oncology (Williston Park, N.Y.)
ISSN
0890-9091
Publication Date
March 1, 2013
Volume
27
Issue
3
Citation
APA
Chicago
ICMJE
MLA
NLM
Hamilton, E. P., & Blackwell, K. L. (2013). How can we optimize treatment of HER2-positive metastatic breast cancer? Oncology (Williston Park, N.Y.), 27(3).
Hamilton, E. P., and K. L. Blackwell. “How can we optimize treatment of HER2-positive metastatic breast cancer?” Oncology (Williston Park, N.Y.) 27, no. 3 (March 1, 2013).
Hamilton EP, Blackwell KL. How can we optimize treatment of HER2-positive metastatic breast cancer? Oncology (Williston Park, NY). 2013 Mar 1;27(3).
Hamilton, E. P., and K. L. Blackwell. “How can we optimize treatment of HER2-positive metastatic breast cancer?” Oncology (Williston Park, N.Y.), vol. 27, no. 3, Mar. 2013.
Hamilton EP, Blackwell KL. How can we optimize treatment of HER2-positive metastatic breast cancer? Oncology (Williston Park, NY). 2013 Mar 1;27(3).
Published In
Oncology (Williston Park, N.Y.)
ISSN
0890-9091
Publication Date
March 1, 2013
Volume
27
Issue
3